Cargando…

Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma

Primary liver cancer has become the second most fatal cancer in the world, and its five-year survival rate is only 10%. Most patients are in the middle and advanced stages at the time of diagnosis, losing the opportunity for radical treatment. Liver cancer is not sensitive to chemotherapy or radioth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Mengjiao, Yang, Liu, Lin, Yanjie, Lu, Yao, Bi, Xiaoyue, Jiang, Tingting, Deng, Wen, Zhang, Lu, Yi, Wei, Xie, Yao, Li, Minghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524074/ https://www.ncbi.nlm.nih.gov/pubmed/36175957 http://dx.doi.org/10.1186/s12951-022-01615-2

Ejemplares similares

Nanobiotechnology
por: Diniz, Susana N., et al.
Publicado: (2013)

Emerging Applications of Bacterial Spores in Nanobiotechnology
por: Ricca, Ezio, et al.
Publicado: (2003)

An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients
por: Li, Minghui, et al.
Publicado: (2022)

Nomogram for evaluating obvious liver inflammation in treatment-naïve HBeAg positive chronic hepatitis B virus infection patients with normal ALT
por: Zhang, Lu, et al.
Publicado: (2023)

Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B
por: Li, Minghui, et al.
Publicado: (2022)

Nanobiotechnology of Biomimetic Membranes
por: Martin, Donald K
Publicado: (2007)

Nanobiotechnology and blood substitutes
por: Saini, Rajiv, et al.
Publicado: (2011)

Editorial: Methods in nanobiotechnology
por: Gentile, Piergiorgio, et al.
Publicado: (2022)

New trends in nanobiotechnology
por: Show, Pau-Loke, et al.
Publicado: (2023)

Therapeutic applications of nanobiotechnology
por: Dutt, Yogesh, et al.
Publicado: (2023)

Advancement of Peptide Nanobiotechnology via Emerging Microfluidic Technology
por: Chan, Kiat Hwa, et al.
Publicado: (2019)

The Promise of Emergent Nanobiotechnologies for In Vivo Applications and Implications for Safety and Security
por: Arnold, Anne M., et al.
Publicado: (2022)

Nanobiotechnology today: focus on nanoparticles
por: Soloviev, Mikhail
Publicado: (2007)

DNA-Based Applications in Nanobiotechnology
por: Abu-Salah, Khalid M., et al.
Publicado: (2010)

Editorial: Applications of Nanobiotechnology in Pharmacology
por: Qi, Baowen, et al.
Publicado: (2019)

Some Applications of Nanobiotechnology in Parasitology
por: HATAM-NAHAVANDI, Kareem
Publicado: (2019)

The Use of Nanobiotechnology in Immunology and Vaccination
por: Keikha, Reza, et al.
Publicado: (2021)

Imaging tools for plant nanobiotechnology
por: Zhao, Bin, et al.
Publicado: (2022)

Nanobiotechnology: Applications in Chronic Wound Healing
por: Jiang, Tao, et al.
Publicado: (2022)

Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B
por: Xie, Si, et al.
Publicado: (2022)

Changes of natural killer cells’ phenotype in patients with chronic hepatitis B in intermittent interferon therapy
por: Bi, Xiaoyue, et al.
Publicado: (2023)

Study on liver histopathology of chronic HBV infected patients with different normal ALT values
por: Zeng, Zhan, et al.
Publicado: (2022)

Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatment
por: Lin, Yanjie, et al.
Publicado: (2023)

Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection
por: Zhang, Lu, et al.
Publicado: (2023)

Nanobiotechnology in energy, environment and electronics : methods and applications /
Publicado: (2015)

Synthetic plant virology for nanobiotechnology and nanomedicine
por: Steele, John F. C., et al.
Publicado: (2017)

Advanced Analgesic Drug Delivery and Nanobiotechnology
por: Stoicea, Nicoleta, et al.
Publicado: (2017)

Nanobiotechnology in combating CoVid-19
por: Ganapathy, Dhanraj, et al.
Publicado: (2020)

Nanobiotechnology-Enabled mRNA Stabilization
por: Xian, He, et al.
Publicado: (2023)

Biomimetic nanomedicines for precise atherosclerosis theranostics
por: Tao, Ying, et al.
Publicado: (2023)

Review of "Glossary of Biotechnology and Nanobiotechnology Terms" by Kimball Nill
por: Jiang, Ming
Publicado: (2007)

Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy
por: Cao, Weihua, et al.
Publicado: (2022)

Circular RNAs Sparkle in the Diagnosis and Theranostics of Hepatocellular Carcinoma
por: Wang, Menglan, et al.
Publicado: (2021)

A nomogram based on HBeAg, AST, and age to predict non-minimal liver inflammation in CHB patients with ALT <80 U/L
por: Zhang, Lu, et al.
Publicado: (2023)

Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients
por: Li, Minghui, et al.
Publicado: (2022)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
por: Zeng, Zhan, et al.
Publicado: (2023)

Effect of Antiviral Therapy During Pregnancy on Natural Killer Cells in Pregnant Women With Chronic HBV Infection
por: Wang, Fuchuan, et al.
Publicado: (2022)

Nanobiotechnology applications of reconstituted high density lipoprotein
por: Ryan, Robert O
Publicado: (2010)

Nanobiotechnology for sensing applications: from lab to field
por: Kaushik, Ajeet Kumar, et al.
Publicado: (2016)

Colloids for nanobiotechnology: synthesis, characterization and potential applications
por: Parak, Wolfgang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rjvrnl7g8pi63216g472udooeg